Obesity and pulmonary embolism: The mounting evidence of risk and the mortality paradox

Thrombosis Research

Volumn 128, Issue 6, 2011, Pages 518-523

  Stein, Paul D ^a,b   Matta, Fadi ^a,b   Goldman, Jose ^c  

^a ST MARY MERCY HOSPITAL   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Obesity; Pulmonary embolism; Venous thromboembolism

Indexed keywords

FIBRINOLYTIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE HEART INFARCTION; ADOLESCENT; ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DEMENTIA; DIABETES MELLITUS; FEMALE; FIBRINOLYTIC THERAPY; HEART FAILURE; HEMIPARESIS; HEMIPLEGIA; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; KIDNEY DISEASE; LENGTH OF STAY; LEUKEMIA; LIVER DISEASE; LUNG EMBOLISM; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MORTALITY; OBESITY; PARAPLEGIA; PERIPHERAL VASCULAR DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SHOCK; ULCER; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; OBESITY; PREVALENCE; PULMONARY EMBOLISM; RISK FACTORS; UNITED STATES; YOUNG ADULT;

EID: 82355180894     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.10.019     Document Type: Article

References (35)

1. P.D. Stein, A. Beemath, and R.E. Olson Obesity as a risk factor in venous thromboembolism Am J Med 118 2005 978 980 (Pubitemid 41297761)
2. S.Z. Goldhaber, D.D. Savage, R.J. Garrison, W.P. Castelli, W.B. Kannel, and P.M. McNamara Risk factors for pulmonary embolism. The Framingham Study Am J Med 74 1983 1023 1028 (Pubitemid 13101585)
3. W.W. Coon, and F.A. Coller Some epidemiologic considerations of thromboembolism Surg Gynecol Obstet 109 1959 487 501
4. S.Z. Goldhaber, F. Grodstein, M.J. Stampfer, J.E. Manson, G.A. Colditz, and F.E. Speizer A prospective study of risk factors for pulmonary embolism in women JAMA 277 1997 642 645 (Pubitemid 27097428)
5. C. Kabrhel, R. Varraso, S.Z. Goldhaber, E.B. Rimm, and C.A. Camargo Prospective study of BMI and the risk of pulmonary embolism in women Obesity (Silver Spring) 17 2009 2040 2046
6. A.M. Snell The relation of obesity to fatal postoperative pulmonary embolism Arch Surg 15 1927 237 244
7. F.A. Anderson Jr., H.B. Wheeler, R.J. Goldberg, D.W. Hosmer, N.A. Patwardhan, and B. Jovanovic A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study Arch Intern Med 151 1991 933 938
8. F.A. Anderson Jr., H.B. Wheeler, R.J. Goldberg, D.W. Hosmer, and A. Forcier The prevalence of risk factors for venous thromboembolism among hospital patients Arch Intern Med 152 1992 1660 1664
9. P.O. Hansson, H. Eriksson, L. Welin, K. Svardsudd, and L. Wilhelmsen Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: "the study of men born in 1913" Arch Intern Med 159 1999 1886 1890 (Pubitemid 29424708)
10. M. Abdollahi, M. Cushman, and F.R. Rosendaal Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use Thromb Haemost 89 2003 493 498 (Pubitemid 36329240)
11. J.A. Heit, M.D. Silverstein, D.N. Mohr, T.M. Petterson, C.M. Lohse, and W.M. O'Fallon The epidemiology of venous thromboembolism in the community Thromb Haemost 86 2001 452 463 (Pubitemid 32663974)
12. R. Barba, A. Zapatero, J.E. Losa, V. Valdés, J.A. Todolí, and P. Di Micco Riete Investigators. Body mass index and mortality in patients with acute venous thromembolism: Findings from the RIETE registry J Thromb Haemost 6 2008 595 600 (Pubitemid 351404926)
13. HCUP Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP) 1998-2008 Agency for Healthcare Research and Quality Rockville, MD www.hcup-us.ahrq.gov/nisoverview.jsp
14. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383 (Pubitemid 17055592)
15. A.G. Holst, G. Jensen, and E. Prescott Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study Circulation 121 2010 1896 1903
16. J.P. Curtis, J.G. Selter, Y. Wang, S.S. Rathore, I.S. Jovin, and F. Jadbabaie The obesity paradox: body mass index and outcomes in patients with heart failure Arch Intern Med 165 2005 55 61 (Pubitemid 40096082)
17. X. Kang, L.J. Shaw, S.W. Hayes, R. Hachamovitch, A. Abidov, and I. Cohen Impact of body mass index on cardiac mortality in patients with known or suspected coronary artery disease undergoing myocardial perfusion single-photon emission computed tomography J Am Coll Cardiol 47 2006 1418 1426
18. W. Galal, R.T. van Domburg, H.H. Feringa, O. Schouten, A. Elhendy, and J.J. Bax Relation of body mass index to outcome in patients with known or suspected coronary artery disease Am J Cardiol 99 2007 1485 1490 (Pubitemid 46770628)
19. H.J. Buettner, C. Mueller, M. Gick, M. Ferenc, J. Allgeier, and T. Comberg The impact of obesity on mortality in UA/non-ST-segment elevation myocardial infarction Eur Heart J 28 2007 1694 1701 (Pubitemid 47227103)
20. M. Benderly, V. Boyko, and U. Goldbourt Relation of body mass index to mortality among men with coronary heart disease Am J Cardiol 106 2010 297 304
21. N. Pannaciulli, V. De Mitrio, R. Marino, R. Giorgino, and G. De Pergola Effect of glucose tolerance status on PAI-1 plasma levels in overweight and obese subjects Obes Res 10 2002 717 725 (Pubitemid 135687511)
22. I. Juhan-Vague, M.C. Alessi, and A. Mavri Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk J Thromb Haemost 1 2003 1575 1579
23. M. Margaglione, G. Cappuci, M. d'Addedda, D. Colaizzo, N. Giuliani, and G. Vecchione PAI-1 plasma levels in a general population without clinical evidence of atherosclerosis: relation to environmental and genetic determinants Arterioscler Thromb Vasc Biol 18 1998 562 567 (Pubitemid 28177895)
24. L. Bara, V. Nicaud, L. Tiret, F. Cambien, and M.M. Samama Expression of a paternal history of premature myocardial infarction on fibrinogen, factor VIIC and PAI-1 in European offspring-the EARS study. European Atherosclerosis Research Study Group Thromb Haemost 71 1994 434 440 (Pubitemid 24100667)
25. S. Basili, G. Pacini, M.T. Guagnano, M.R. Manigrasso, F. Santilli, and C. Pettinella Insulin resistance as a determinant of platelet activation in obese women J Am Coll Cardiol 48 2006 2531 2538 (Pubitemid 44881227)
26. I. Mertens, and L.F. Van Gaal Obesity, haemostasis and the fibrinolytic system Obes Rev 3 2002 85 101 (Pubitemid 34827150)
27. B. Goichot, L. Grunebaum, D. Desprez, S. Vinzio, L. Meyer, and J.L. Schlienger Circulating procoagulant microparticles in obesity Diabetes Metab 32 2006 82 85 (Pubitemid 43872600)
28. S. Engeli, J. Böhnke, M. Feldpausch, K. Gorzelniak, J. Janke, and S. Bátkai Activation of the peripheral endocannabinoid system in human obesity Diabetes 54 2005 2838 2843 (Pubitemid 41401077)
29. M. Blüher, S. Engeli, N. Klöting, J. Berndt, M. Fasshauer, and S. Bátkai Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity Diabetes 55 2006 3053 3060 (Pubitemid 44923642)
30. A.V. Krylatov, D.S. Ugdyzhekova, N.A. Bernatskaya, L.N. Maslov, R. Mekhoulam, and R.G. Pertwee Activation of Type II Cannabinoid Receptors Improves Myocardial Tolerance to Arrhythmogenic Effects of Coronary Occlusion and Reperfusion Bull Exp Biol Med 131 2001 523 525 (Pubitemid 34051335)
31. D.S. Ugdyzhekova, N.A. Bernatskaya, J.B. Stefano, V.F. Graier, S.W. Tam, and R. Mekhoulam Endogenous Cannabinoid Anandamide Increases Heart Resistance to Arrhythmogenic Effects of Epinephrine: Role of CB1 and CB2 Receptors Bull Exp Biol Med Pharmacol Toxicol 3 2010 251 253
32. W.R. Ford, S.A. Honan, R. White, and C.R. Hiley Evidence of a noverl site mediating anatamide-induced negative inotropic and coronary vasodilator responses in rat isolated hearts Br J Pharmacol 135 2002 1191 1198 (Pubitemid 34259120)
33. P. Lépicier, J.F. Bouchard, C. Lagneux, and D. Lamontagne Endocannabinoids protect the rat isolated heart against ischaemia Br J Pharmacol 139 2003 805 815 (Pubitemid 36819608)
34. N. Defer, J. Wan, R. Souktani, B. Escoubet, M. Perier, and P. Caramelle The cannabinoid receptor type 2 promotes cardiac myocyte and fibriblast survival and protects against ischemia/reperfusion-induced cardiomyopathy FASEB J 23 2009 2120 2130
35. S. Conti, B. Costa, M. Colleoni, D. Parolaro, and G. Giagnoni Antiinflammatory action of endocannabinoid palmitoylethanoamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat Br J Pharmacol 135 2002 181 187 (Pubitemid 34102111)